These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6966305)

  • 21. Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemia.
    O'Meara A; Deasy PF; Hillary IB; Bridgen WD
    Lancet; 1979 Dec; 2(8153):1196. PubMed ID: 91931
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of a thymidine kinase inhibitor (L-653,180) on antiviral treatment of experimental herpes simplex virus infection in mice.
    Klein RJ; Czelusniak SM
    Antiviral Res; 1990; 14(4-5):207-14. PubMed ID: 2088206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific herpes simplex virus-induced incorporation of 5-iodo-5'-amino-2',5'-dideoxyuridine into deoxyribonucleic acid.
    Chen MS; Ward DC; Prusoff WH
    J Biol Chem; 1976 Aug; 251(16):4833-8. PubMed ID: 182681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New strategies against drug resistance to herpes simplex virus.
    Jiang YC; Feng H; Lin YC; Guo XR
    Int J Oral Sci; 2016 Mar; 8(1):1-6. PubMed ID: 27025259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyclovir: is it an effective virostatic agent for orofacial infections?
    Lavelle CL
    J Oral Pathol Med; 1993 Oct; 22(9):391-401. PubMed ID: 8301603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent herpes labialis: current treatment perspectives.
    Sciubba JJ
    Compend Contin Educ Dent; 2002 Jul; 23(7 Suppl 2):9-12. PubMed ID: 12789981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex: nature and treatment of the disease.
    Park NH; Geary PA; August ML
    Dent Assist (1931); 1981; 50(2):23, 26-7. PubMed ID: 6793417
    [No Abstract]   [Full Text] [Related]  

  • 29. Iontophoretic treatment of oral herpes.
    Henley-Cohn J; Hausfeld JN
    Laryngoscope; 1984 Jan; 94(1):118-21. PubMed ID: 6690869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incorporation of 5-iodo-5'-amino-2',5-dideoxyuridine and 5-iodo-2'-deoxyuridine into herpes simplex virus DNA. Relationship between antiviral activity and effects on DNA structure.
    Fischer PH; Chen MS; Prusoff WH
    Biochim Biophys Acta; 1980 Feb; 606(2):236-45. PubMed ID: 6243982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
    Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of acyclovir in herpetic ocular infection.
    McGill J; Tormey P
    Am J Med; 1982 Jul; 73(1A):286-9. PubMed ID: 7102708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
    Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus: clinical presentation and treatment.
    Ryan WA
    Dent Today; 2001 May; 20(5):64-7. PubMed ID: 11443814
    [No Abstract]   [Full Text] [Related]  

  • 36. Acyclovir for herpes: no clinical payoff yet.
    Check WA
    JAMA; 1980 Nov; 244(18):2021-2. PubMed ID: 6253689
    [No Abstract]   [Full Text] [Related]  

  • 37. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Antimicrob Agents Chemother; 1979 May; 15(5):723-9. PubMed ID: 230784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
    Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
    J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
    Trousdale MD; Dunkel EC; Nesburn AB
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of oral and genital herpes simplex virus infections: diagnosis and treatment.
    Pazin GJ; Harger JH
    Dis Mon; 1986 Dec; 32(12):725-824. PubMed ID: 3641715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.